Home > Newsletters > FDAnews Device Daily Bulletin > PAD Endovascular Stapling Device: To Use or Not to Use?
FDAnews Device Daily Bulletin
Sept. 12, 2012 | Vol. 9 No. 179
PAD Endovascular Stapling Device: To Use or Not to Use?
Intact Vascular announced the completion of a $15.5 million Series A round. Series A financing is the first round of financing undergone for a new business venture after seed capital, where company ownership is often offered to external investors. Intact Vascular will use the money to conduct clinical studies and market its Tack-It-Endovascular Stapler System, a new technology for treating peripheral artery disease, which received CE mark certification earlier this year.
New Zealand Doctor Online
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.